Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines

被引：58

作者：

Bianchi, Diana W. ^{[1
]}

Kaeser, Lisa ^{[1
]}

Cernich, Alison N. ^{[1
]}

机构：

[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 10, Bethesda, MD 20892 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2021年 / 325卷 / 11期

关键词：

D O I：

10.1001/jama.2021.1865

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Viewpoint from the National Institute of Child Health and Human Development emphasizes the need to use existing data sources and develop partnerships, infrastructure, and ethical and regulatory standards to generate data about the safety and efficacy of COVID-19 vaccination in pregnant individuals.

引用

页码：1041 / 1042

页数：2

共 7 条

[1]

[Anonymous], 2020, VACCINES RELATED BIO

[2]

CDC, ENS SAF COVID 19 VAC

[3]

Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2020, TASK FORC RES SPEC P

[4]

Health Resources & Services Administration, COUNT INJ COMP PROGR

[5] Pharmacometrics in Pregnancy: An Unmet Need [J].

Ke, Alice Ban ;

Rostami-Hodjegan, Amin ;

Zhao, Ping ;

Unadkat, Jashvant D. .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 :53-69

[6]

Metz TD, 2021, AM J OBSTET GYNECOL, V224, pS722

[7] Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020 [J].

Zambrano, Laura D. ;

Ellington, Sascha ;

Strid, Penelope ;

Galang, Romeo R. ;

Oduyebo, Titilope ;

Tong, Van T. ;

Woodworth, Kate R. ;

Nahabedian, John F., III ;

Azziz-Baumgartner, Eduardo ;

Gilboa, Suzanne M. ;

Meaney-Delman, Dana .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (44) :1641-1647

← 1 →